drugset / Trial / NCT03997370

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

NCT03997370

Phase 1 Active not recruiting 318 enrolled NRG Oncology National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment

Summary

This trial studies how well iohexol works in helping doctors calculate the dose of carboplatin given to patients with cancer. Drugs used in chemotherapy, such as carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Understanding how to best calculate the dose of carboplatin given to patients with cancer may help doctors learn how to improve the use of carboplatin in the future.

Timeline

Start
2020-01-15
Primary completion
2027-02-06
Completion
2028-02-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule Intravenous
Subject Iohexol Diagnostic / imaging agent Intravenous

Indications